Myriad Genetics Inc (NAS:MYGN)
$ 26.84 0.45 (1.71%) Market Cap: 2.44 Bil Enterprise Value: 2.44 Bil PE Ratio: 0 PB Ratio: 3.29 GF Score: 78/100

Q1 2020 Myriad Genetics Inc Earnings Call Transcript

Nov 04, 2019 / 09:30PM GMT
Release Date Price: $35.1 (+3.85%)
Operator

Greetings and welcome to the Myriad Genetics First Quarter 2020 Financial Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded Monday, November 4, 2019.

I would now like to turn the conference over to Scott Gleason, VP of Investor Relations. Please go ahead.

Scott Gleason
Myriad Genetics, Inc. - VP of IR

Thanks, Grant. Good afternoon and welcome to Myriad Genetics Fiscal First Quarter 2020 Earnings Call. During the call, we will review the financial results we've released today, after which we'll host a question-and-answer session. If you've not had a chance to review our quarterly earnings release, it can be found on our website on myriad.com.

Presenting for Myriad today will be Mark Capone, President and Chief Executive Officer; and Bryan Riggsbee, Chief Financial Officer.

This call can be heard live via webcast at myriad.com, and a recording will be archived in the Investor section of our website. In addition, there is a slide presentation pertaining to today's earnings call on the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot